CASR and familial isolated hyperparathyroidism: This inference follows from the fact that nearly 70% of families initially characterized with an FIHP phenotype in several clinical studies that screened for germline MEN1, CASR, and CDC73/HRPT2 gene mutation, were found to have no currently recognized syndromic or genetic basis (Figure 2) (20, 119–121).